| dc.contributor.author | Stuopis, Cecilia | |
| dc.contributor.author | Schuetz, Brian | |
| dc.date.accessioned | 2024-08-30T19:50:21Z | |
| dc.date.available | 2024-08-30T19:50:21Z | |
| dc.date.issued | 2023-06-30 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/156518 | |
| dc.description.abstract | This report contains the following sections: Introduction to FY2023; About MIT Medical; Core Values; MIT Medical evolves its response to the COVID-19 pandemic and continues to take the lead in campuswide infection-control efforts; Improving Patient Experience and Patient Outcomes through; Technology and Outreach; Space Improvements to Enhance Comfort, Privacy, and Workspaces; Envisioning the Future of MIT Medical through Strategic Planning and Brand Exploration; Financials, Utilization, and Human Resources Information; MIT Medical Utilization; MIT Medical Financial Stewardship; Concluding Thoughts | en_US |
| dc.rights | In Copyright - Educational Use Permitted | |
| dc.rights.uri | https://rightsstatements.org/page/InC-EDU/1.0/ | |
| dc.title | Report to the President for year ended June 30, 2023, MIT Medical | en_US |
| dc.contributor.department | MIT Medical | |
